PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7517700-5	1994	IGF-I at 10-100 ng/ml stimulated 3H-thymidine incorporation in quiescent stromal and smooth muscle cells with maximal effect at 100 ng/ml (p < 0.05).	3h-thymidine	33-45	insulin like growth factor 1	Homo sapiens	0-5	
15994346-6	2005	IGF-I (100 ng/ml) increased incorporation of 3H-thymidine in neuroblastoma SK-N-SHEP cells by approximately 30%, an effect blunted by exogenously added native or either mutant IGFBP-2.	3h-thymidine	45-57	insulin like growth factor 1	Homo sapiens	0-5	
15812560-5	2005	Insulin-like growth factor-I is a growth factor for KSIMM cells with a maximum increase of 3H-thymidine incorporation of 130 +/- 27.6% (P < 0.05) similar to that induced by VEGF and with which it is additive (281 +/- 13%) (P < 0.05).	3h-thymidine	91-103	insulin like growth factor 1	Homo sapiens	0-28	
11966736-3	2002	DESIGN AND MEASUREMENTS: The mitogenic responsiveness to GH and IGF-I was investigated by 3H-Thymidine incorporation.	3h-thymidine	90-102	insulin like growth factor 1	Homo sapiens	64-69	
1752778-2	1991	It was found that (1) the tumor growth and the proportion of 3H-thymidine-labeled cells were significantly increased in the 17 beta-estradiol dipropionate (E2) group, but significantly decreased in the tamoxifen (TAM) group with respect to the control group, and (2) the tumor content of insulin-like growth factor-1 (IGF-1) and the rate of IGF-1-positive cells were significantly lower in the E2 group, but significantly higher in the TAM group than in the control group.	3h-thymidine	61-73	insulin like growth factor 1	Homo sapiens	288-316	
7968218-8	1994	The effects of human MGF on IMR 90 cells (increases in cell number, incorporation of 3H-thymidine and DNA amount) were dose dependent.	3h-thymidine	85-97	insulin like growth factor 1	Homo sapiens	21-24	
7968218-9	1994	The activating effect on incorporation of 3H-thymidine (methyl-3H) was suppressed by anti-human MGF antibody in a dose-dependent manner.	3h-thymidine	42-54	insulin like growth factor 1	Homo sapiens	96-99	
1474468-10	1992	Incorporation of 3H-thymidine, however, was increased in a dose-dependent manner by IGF-I, whereas hGH alone or in combination with IGF-I produced no dose-dependent response.	3h-thymidine	17-29	insulin like growth factor 1	Homo sapiens	84-89	
8113863-5	1994	Suramin inhibited the IGF-I-induced incorporation of 3H-thymidine into meningioma cells in a dose-dependent manner, with an IC50 of 4.6 +/- 1.4 x 10(-5) M. The growth rate of meningioma cells (determined 4 days after seeding) was reduced by 10%, 20%, and 50% of the control culture in the presence of 10(-6), 10(-5), and 10(-4) M suramin, respectively.	3h-thymidine	53-65	insulin like growth factor 1	Homo sapiens	22-27	
7691836-12	1993	Immunoblotting of the CM obtained at the end of the 3H-thymidine assay showed a loss of intact IGFBP-4 in the cultures containing IGF-I.	3h-thymidine	52-64	insulin like growth factor 1	Homo sapiens	130-135	
1721071-6	1991	The inhibitory effect of hIGFBP-1 on IGF-1 mediated 3H-thymidine incorporation into DNA was dose dependent.	3h-thymidine	52-64	insulin like growth factor 1	Homo sapiens	37-42	
1752778-2	1991	It was found that (1) the tumor growth and the proportion of 3H-thymidine-labeled cells were significantly increased in the 17 beta-estradiol dipropionate (E2) group, but significantly decreased in the tamoxifen (TAM) group with respect to the control group, and (2) the tumor content of insulin-like growth factor-1 (IGF-1) and the rate of IGF-1-positive cells were significantly lower in the E2 group, but significantly higher in the TAM group than in the control group.	3h-thymidine	61-73	insulin like growth factor 1	Homo sapiens	318-323	
1752778-2	1991	It was found that (1) the tumor growth and the proportion of 3H-thymidine-labeled cells were significantly increased in the 17 beta-estradiol dipropionate (E2) group, but significantly decreased in the tamoxifen (TAM) group with respect to the control group, and (2) the tumor content of insulin-like growth factor-1 (IGF-1) and the rate of IGF-1-positive cells were significantly lower in the E2 group, but significantly higher in the TAM group than in the control group.	3h-thymidine	61-73	insulin like growth factor 1	Homo sapiens	341-346	
2693820-6	1989	At concentrations of insulin or IGF I that produced a maximum stimulation of 3H-thymidine incorporation, the addition of bTSH did result in a slight decrease rather than a further increase of that stimulation.	3h-thymidine	77-89	insulin like growth factor 1	Homo sapiens	32-37	
2960684-7	1987	IGF-I and insulin increased HL60 cell proliferation, as assessed by 3H-thymidine uptake, IGF-I greater than insulin.	3h-thymidine	68-80	insulin like growth factor 1	Homo sapiens	0-5	
2245830-3	1990	Insulin-like growth factor I (1 to 10 ng/mL) significantly stimulated 3H-thymidine incorporation in granulosa cells obtained from both natural cycles and from patients stimulated for in vitro fertilization, whereas luteinizing hormone (LH, 10 ng/mL), follicle-stimulating hormone (FSH, 10 ng/mL) and epidermal growth factor (EGF, 10 ng/mL) had no apparent effect on deoxyribonucleic acid (DNA) synthesis under these conditions.	3h-thymidine	70-82	insulin like growth factor 1	Homo sapiens	0-28	
2559767-4	1989	In addition, IGF-I and EGF synergistically increased 3H-thymidine incorporation into DNA synthesis by the primary cultured meningioma cells, in dose-dependent manner.	3h-thymidine	53-65	insulin like growth factor 1	Homo sapiens	13-18	
2967213-10	1988	Both IGF-I and II stimulated 3H-thymidine incorporation into K562 cells whereas insulin was without effect.	3h-thymidine	29-41	insulin like growth factor 1	Homo sapiens	5-10